T. Rowe Price Associates
CLMT icon

T. Rowe Price Associates’s Calumet Specialty Products CLMT Stock Holding History

T. Rowe Price Associates’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Buy
49,893
+8,605
+21% +$223K ﹤0.01% 1869
2025
Q4 		$821K Buy
41,288
+3,688
+10% +$71K ﹤0.01% 2164
2025
Q3 		$687K Buy
37,600
+3,149
+9% +$51.8K ﹤0.01% 2237
2025
Q2 		$543K Buy
+34,451
New +$438K ﹤0.01% 2263

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates's CLMT Position: Q1 2026 in Review

T. Rowe Price Associates increased its Calumet Specialty Products (CLMT) stake by 21% in Q1 2026, buying an estimated $223K and bringing the position to 49,893 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1869.

T. Rowe Price Associates first reported a position in CLMT in Q2 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • T. Rowe Price Associates held 49,893 shares of Calumet Specialty Products worth $1.79M as of Q1 2026.
  • T. Rowe Price Associates bought 8,605 Calumet Specialty Products shares in Q1 2026, an estimated $223K.
  • Calumet Specialty Products made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1869 holding.
  • T. Rowe Price Associates first reported a position in Calumet Specialty Products in Q2 2025 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.